The U.S. Department of Health and Human Services (HHS) is re-evaluating its stance on fluoride in drinking water by reconvening the Community Preventive Services Task Force, an independent panel of health experts. This move follows Health Secretary Robert F. Kennedy Jr.’s recent statement in Salt Lake City, indicating plans to halt the Centers for Disease Control and Prevention’s recommendation for community water fluoridation.
Fluoride, commonly added to public water supplies to prevent tooth decay, has been a controversial topic for decades. While the American Dental Association continues to support fluoridation as an effective dental health measure, concerns about potential health risks have gained traction.
The Environmental Protection Agency (EPA) will also review new scientific data on fluoride’s health effects. EPA Administrator Lee Zeldin confirmed that this effort is in collaboration with HHS, with the goal of re-evaluating the agency’s current enforceable fluoride limit of 4.0 milligrams per liter (mg/L). Currently, the U.S. Public Health Service recommends maintaining levels below 0.7 mg/L. Studies show that exposure above 1.5 mg/L can increase risks of bone fractures, thyroid dysfunction, and neurological damage.
In a landmark move, Utah became the first state to ban fluoride in public water systems after Governor Spencer Cox signed new legislation last month. The decision faced strong opposition from health experts and organizations, including the American Dental Association.
As of 2022, about 63% of Americans receive fluoridated water through their municipal systems. A 2024 federal court ruling ordered the EPA to tighten its standards, citing unacceptable health risks to children under current fluoride levels. While Kennedy claims links between fluoride and conditions like cancer, his statements remain unsubstantiated by definitive scientific evidence.


FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Trump Signs Order to Ease Federal Marijuana Rules, Signaling Major Policy Shift
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate
Syria, Kurds and U.S. Race to Show Progress on SDF Integration Deal
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Dan Bongino to Step Down as FBI Deputy Director After Brief, Controversial Tenure
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Kennedy Center Reportedly Renamed Trump-Kennedy Center After Board Vote
Honduras Election Recount Delayed Amid Protests and Political Tensions
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium 



